BAT to Cut 9,000 Jobs in AI Cost-Saving Programme

The Scale of Workforce Reductions

British American Tobacco announced on Monday plans to cut 5,500 positions outright while shifting a further 3,500 roles to external providers such as Accenture. The combined impact reaches 9,000 positions, representing roughly one fifth of the company's global workforce. These reductions spare the United States operations, which remain the firm's largest single market by revenue.

The announcement follows earlier signals in February that a productivity drive would affect staffing levels. Consultations with affected staff have already concluded in many locations, with remaining discussions proceeding under local employment rules. Chief executive Tadeu Marroco stated that the company would support colleagues through the transition with care and respect, though the precise terms of severance and redeployment remain under negotiation in several countries.

Traditional tobacco operations face structural contraction, with BAT forecasting a 2.5 per cent industry-wide volume decline this year. The scale of the job losses reflects the urgency to align headcount with shrinking cigarette demand while reallocating resources toward newer product categories. Employees in manufacturing, commercial and corporate functions across multiple regions stand to be affected.

AI Transformation and Cost Programme

The restructuring forms part of an AI-driven transformation programme intended to generate £600 million in annualised incremental savings by 2028. Of that total, £500 million is already targeted for delivery by 2027. The initiative combines technology adoption with organisational simplification to improve margins amid sluggish sales growth.

Marroco described the changes as necessary to create a more agile, cost-disciplined and technology-enabled organisation. The programme builds on guidance issued in June that left group-wide financial targets unchanged despite the anticipated headcount reductions. Investors had been prepared for some level of restructuring, yet the breadth of the measures has drawn attention from analysts monitoring execution risk.

Cost discipline has become central to BAT's strategy as traditional tobacco volumes contract and regulatory pressures mount. The company expects the combination of artificial intelligence tools and third-party outsourcing to accelerate decision-making and reduce overheads without compromising core commercial operations outside the United States.

US Regulatory Pressures and Chinese Competition

Sales growth in the critical American market has been hampered by regulatory delays that have slowed the introduction of new products. These constraints have allowed unauthorised Chinese competitors to capture share by selling vapes without the required marketing authorisations from the Food and Drug Administration. BAT has repeatedly highlighted the uneven enforcement environment as a drag on legitimate operators.

Domestic consumers have also traded down to cheaper cigarette brands in response to the rising cost of living. Combined with higher excise duties and stricter packaging rules in several states, these factors have compressed volumes and pricing power. The company continues to navigate a patchwork of state and federal requirements that differ markedly from the more permissive regimes in parts of Asia and Latin America.

Illicit trade has compounded difficulties in other key territories, notably Australia and Bangladesh, where rising duties have fuelled black-market activity. BAT has argued that coordinated enforcement action is essential if legal manufacturers are to compete on fair terms. The absence of such measures has contributed to the decision to accelerate cost reductions elsewhere in the group.

Strategic Shift to Vaping Alternatives versus Philip Morris

BAT is accelerating its transition toward heated tobacco, vapes and nicotine pouches, with Vuse and Velo positioned as the primary growth engines. Progress has nevertheless lagged behind rival Philip Morris International, which secured earlier regulatory clearances for its heated tobacco platform in several major markets. The gap in approved product portfolios has limited BAT's ability to offset cigarette volume declines at the same pace.

Investors have expressed frustration that revenue and profit growth have repeatedly fallen short of or merely met internal targets in recent reporting periods. The new cost programme is presented as a means to fund continued investment in reduced-risk products while protecting cash generation. Success will depend on securing timely regulatory approvals and scaling distribution in markets where adult smokers are willing to switch.

Competition in the nicotine pouch category has intensified, with multiple entrants seeking shelf space in convenience stores and online channels. BAT's ability to defend and expand its position will influence whether the savings delivered by the restructuring can be redeployed into marketing and innovation at sufficient scale.

Impact on UK Workers, London Headquarters and FTSE Standing

As a FTSE-listed company headquartered in London, BAT's restructuring carries direct implications for British employees and the wider corporate ecosystem that supports the firm. While the United States has been excluded from the cuts, operations in the United Kingdom and other European locations face reductions that will affect both manufacturing sites and central functions.

The company's presence in the capital supports a network of professional services firms, from legal advisers to technology contractors. Any contraction in headcount at the London centre may influence demand for office space and related services in an already pressured commercial property market. Trade unions representing BAT workers have begun discussions with management over the sequencing of redundancies and the availability of retraining support.

UK pension schemes linked to the company will monitor the financial impact of the programme, particularly the timing of one-off restructuring charges. The broader tobacco sector's contribution to Treasury revenues through excise duties remains substantial, yet sustained volume declines could eventually affect fiscal receipts if alternative nicotine products do not fully compensate.

Market Reaction and Analyst Assessment

Shares in British American Tobacco fell 1.3 per cent in early trading following the announcement, reflecting investor caution over the execution of such a wide-ranging programme. Barclays analyst Pallav Mittal noted that the breadth of the reductions could still surprise the market despite the earlier February warning. The note highlighted both the potential for meaningful margin improvement and the risks associated with large-scale organisational change.

Analysts will focus on quarterly updates for evidence that the targeted £600 million in savings is being realised without disruption to commercial momentum. The decision to outsource 3,500 roles to third parties introduces additional variables around service quality and intellectual property protection that will require close oversight.

Longer-term valuation will hinge on whether the combination of cost discipline and renewed focus on reduced-risk products can restore consistent earnings growth. With traditional tobacco volumes in structural decline, the restructuring represents a pivotal attempt to reposition the company for a lower-combustible future while maintaining returns for shareholders.